GO:0071397 cellular response to cholesterol: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071397 cellular response to cholesterol describes any process by which a cell changes its state or activity in response to a cholesterol stimulus.
• Cholesterol is not only a membrane lipid but also a signaling molecule that modulates innate immunity, inflammation, and cancer cell survival.
• Key molecular players include SLC38A9, NPC1, mTORC1, LXR, IDOL, and the LDL receptor, which together sense and respond to cholesterol levels.
• Dysregulated cellular cholesterol responses contribute to endometrial cancer progestin resistance, colorectal cancer radioresistance, and immunosuppressive tumor microenvironments.
• Cholesterol-dependent cytolysins (CDCs) exploit the cellular cholesterol response to form pores and modulate immune signaling.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect causal roles of cholesterol-responsive genes in disease.
Description
Cellular response to cholesterol (GO:0071397) is a biological process that encompasses the changes in cell state or activity triggered by cholesterol. Cholesterol is a sterol lipid essential for membrane integrity, but it also acts as a signaling molecule that influences gene expression, secretion, and cell movement. The QuickGO definition states that this process results in a change in state or activity of a cell as a result of a cholesterol stimulus. This term is critical for understanding how cells sense and adapt to cholesterol levels, which is relevant to immunity, cancer, and metabolic disorders. Research has shown that cholesterol accumulation in lysosomes activates mTORC1 through an SLC38A9-Niemann-Pick C1 signaling complex, linking cholesterol sensing to nutrient signaling. In cancer, cholesterol desensitizes endometrial cancer cells to progestin by attenuating progestin signaling, highlighting its clinical importance. Furthermore, cholesterol biosynthesis induced by radiotherapy inhibits cGAS-STING activation and contributes to colorectal cancer treatment resistance. These examples underscore why GO:0071397 is a focal point for researchers studying cell signaling, disease mechanisms, and therapeutic resistance.
cellular response to cholesterol At A Glance
| GO ID | GO:0071397 |
|---|---|
| GO term | cellular response to cholesterol |
| Ontology | biological_process |
| Synonym | none |
| Major function | Mediates cellular adaptation to cholesterol stimuli, influencing signaling, gene expression, and metabolism |
| Key signaling node | mTORC1 activation via SLC38A9-NPC1 complex in lysosomes |
| Transcriptional regulator | LXR regulates cholesterol uptake through IDOL-dependent ubiquitination of LDL receptor |
| Disease relevance | Cancer progestin resistance, radioresistance, and immunosuppression |
| Experimental models | CRISPR knockout, knock-in, overexpression in cancer and immune cells |
What Is GO:0071397?
In our own words, GO:0071397 cellular response to cholesterol refers to any cellular process that is initiated or modified by exposure to cholesterol, leading to changes in cell behavior, gene expression, enzyme production, secretion, or movement. This includes signaling cascades, transcriptional reprogramming, and metabolic adjustments that help the cell cope with or utilize cholesterol.
Why Is cellular response to cholesterol Important in Cell Biology?
Understanding cellular response to cholesterol is crucial because cholesterol is a central metabolite and signaling molecule that impacts innate immunity, inflammation, and cancer progression. Dysregulation of this response can lead to treatment resistance, as seen in endometrial cancer where cholesterol desensitizes cells to progestin, and in colorectal cancer where cholesterol biosynthesis inhibits cGAS-STING activation and reduces radiotherapy efficacy. Moreover, cholesterol accumulation in lysosomes activates mTORC1, linking cholesterol sensing to cell growth control. Therefore, studying GO:0071397 provides insights into fundamental cell biology and identifies therapeutic targets.
• Cholesterol is a key regulator of innate immunity and inflammation, influencing macrophage function.
• Lysosomal cholesterol activates mTORC1 via SLC38A9-NPC1, connecting cholesterol to nutrient signaling.
• LXR regulates cholesterol uptake by promoting IDOL-dependent ubiquitination of the LDL receptor.
• Cholesterol desensitizes endometrial cancer to progestin therapy by attenuating progestin signaling.
• Radiotherapy-induced cholesterol biosynthesis inhibits cGAS-STING and drives colorectal cancer resistance.
• Cancer cell-intrinsic XBP1 promotes cholesterol production and immunosuppressive reprogramming.
• Cholesterol-dependent cytolysins exploit cholesterol to form pores and modulate immune responses.
• Cellular cholesterol responses are implicated in neurodegenerative and cardiovascular diseases.
• Targeting cholesterol response pathways may overcome therapy resistance in multiple cancers.
• CRISPR screens can identify novel genes in the cellular response to cholesterol.
What Happens During cellular response to cholesterol?
Cholesterol Sensing at the Lysosome
In simple terms: The cell detects cholesterol levels inside lysosomes, the recycling centers.
Lysosomal cholesterol activates mTORC1 through an SLC38A9-Niemann-Pick C1 signaling complex. This complex senses cholesterol and transmits signals to mTORC1, which then promotes cell growth and metabolism. This step is a primary event in the cellular response to cholesterol, linking lipid availability to nutrient signaling.
Transcriptional Regulation by LXR
In simple terms: The cell turns genes on or off to manage cholesterol uptake and efflux.
The liver X receptor (LXR) regulates cholesterol uptake through IDOL-dependent ubiquitination of the LDL receptor. When cholesterol levels are high, LXR activation leads to IDOL-mediated degradation of LDLR, reducing further cholesterol uptake. This feedback loop is a classic example of the cellular response to cholesterol at the transcriptional level.
Inflammatory and Immune Signaling
In simple terms: Cholesterol can trigger inflammation and immune responses.
Cholesterol crystals and cholesterol accumulation can activate the NLRP3 inflammasome and promote inflammation. Tall et al. reviewed how cholesterol, inflammation, and innate immunity are interconnected, with cholesterol influencing macrophage polarization and cytokine production. This response is part of the cellular reaction to cholesterol stimuli.
Cholesterol-Dependent Cytolysin Response
In simple terms: Some bacterial toxins use cholesterol to punch holes in cells, and cells react to this attack.
Cholesterol-dependent cytolysins (CDCs) bind to cholesterol in membranes to form pores. The cellular response to these toxins involves membrane repair, signaling, and immune activation. Cassidy et al. described the cellular response to CDCs, which is a specialized case of cellular response to cholesterol. Macrophages interact with CDCs, impacting immune response and survival.
Metabolic Reprogramming in Cancer
In simple terms: Cancer cells change their cholesterol metabolism to survive and resist treatment.
In endometrial cancer, cholesterol desensitizes cells to progestin by attenuating progestin signaling, leading to treatment resistance. In colorectal cancer, radiotherapy induces cholesterol biosynthesis, which inhibits cGAS-STING activation and contributes to resistance. Cancer cell-intrinsic XBP1 drives cholesterol production and immunosuppressive reprogramming of myeloid cells. These examples show how the cellular response to cholesterol can be hijacked in disease.
Key Genes Involved in GO:0071397 cellular response to cholesterol
The following genes and proteins are central to the cellular response to cholesterol, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC38A9 | Lysosomal cholesterol sensor; activates mTORC1 | Links cholesterol to nutrient signaling |
| NPC1 | Lysosomal cholesterol transporter; part of SLC38A9-NPC1 complex | Mutations cause Niemann-Pick disease; involved in mTORC1 activation |
| mTORC1 | Kinase complex that promotes growth in response to cholesterol | Central node in cholesterol sensing |
| LXR (NR1H3/NR1H2) | Nuclear receptor regulating cholesterol uptake and efflux | Transcriptional regulator of IDOL and LDLR |
| IDOL (MYLIP) | E3 ubiquitin ligase that degrades LDL receptor | Mediates LXR-dependent cholesterol uptake regulation |
| LDLR | Cell surface receptor for LDL cholesterol uptake | Target of IDOL ubiquitination |
| XBP1 | Transcription factor driving cholesterol production | Promotes immunosuppressive reprogramming in cancer |
| cGAS | DNA sensor that activates STING | Inhibited by cholesterol biosynthesis after radiotherapy |
| STING (TMEM173) | Adaptor in innate immune signaling | Cholesterol biosynthesis inhibits its activation |
| PCSK9 | Regulates LDLR degradation | Potential modulator of cholesterol response |
| ABCA1 | Cholesterol efflux transporter | LXR target gene; involved in cholesterol efflux |
| ABCG1 | Cholesterol efflux transporter | LXR target gene; involved in cholesterol efflux |
| SREBP2 | Transcription factor regulating cholesterol synthesis | Master regulator of cholesterol biosynthesis |
| HMGCR | Rate-limiting enzyme in cholesterol synthesis | Target of statins; induced by radiotherapy |
| NLRP3 | Inflammasome sensor activated by cholesterol crystals | Links cholesterol to inflammation |
| IL-1β | Pro-inflammatory cytokine | Produced in response to cholesterol crystals |
| CDCs (e.g., pneumolysin) | Pore-forming toxins that bind cholesterol | Model for cellular response to cholesterol |
How Is cellular response to cholesterol Regulated?
The cellular response to cholesterol is regulated at multiple levels. Lysosomal cholesterol activates mTORC1 via the SLC38A9-NPC1 complex, which integrates cholesterol availability with growth signals. The LXR-IDOL-LDLR axis provides negative feedback: LXR activation by cholesterol induces IDOL, which ubiquitinates and degrades LDLR, reducing cholesterol uptake. In cancer, XBP1 drives cholesterol production and immunosuppressive reprogramming. Radiotherapy-induced cholesterol biosynthesis inhibits cGAS-STING, linking cholesterol synthesis to innate immune suppression. These regulatory mechanisms ensure tight control of cholesterol homeostasis and responses.
cellular response to cholesterol and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC38A9 | Cholesterol sensing and mTORC1 activation | Knockout in cancer cell lines to study mTORC1 signaling |
| XBP1 | Immunosuppressive reprogramming in cancer | Knockout in cancer cells to assess myeloid cell polarization |
| cGAS/STING | Radiotherapy resistance in colorectal cancer | Knockout or overexpression to study cholesterol-mediated inhibition |
| LXR/IDOL | Cholesterol uptake regulation | Knockout or knock-in to study LDLR degradation |
| NPC1 | Niemann-Pick disease and cholesterol trafficking | Point mutations to model disease |
Endometrial Cancer and Progestin Resistance
Cholesterol desensitizes endometrial cancer to progestin by attenuating progestin signaling. This was demonstrated in a study showing that cholesterol accumulation reduces the efficacy of progestin therapy, suggesting that targeting cholesterol metabolism could restore sensitivity.
Colorectal Cancer and Radiotherapy Resistance
Radiotherapy induces cholesterol biosynthesis, which inhibits cGAS-STING activation and contributes to treatment resistance in colorectal cancer. Inhibiting cholesterol synthesis may enhance the efficacy of radiotherapy by restoring cGAS-STING signaling.
Immunosuppressive Tumor Microenvironment
Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production. This highlights how cholesterol metabolism in cancer cells can shape the immune microenvironment and affect immunotherapy outcomes.
Innate Immunity and Inflammation
Cholesterol accumulation and crystallization activate the NLRP3 inflammasome and promote inflammation. Tall et al. reviewed the links between cholesterol, inflammation, and innate immunity, emphasizing the role of cholesterol in macrophage function and cytokine production.
From cellular response to cholesterol-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC38A9 mediate cholesterol-induced mTORC1 activation? | SLC38A9 knockout cells |
| Does cholesterol desensitize endometrial cancer to progestin? | Endometrial cancer cells with cholesterol loading |
| Does radiotherapy-induced cholesterol biosynthesis inhibit cGAS-STING? | Colorectal cancer cells with HMGCR knockout or overexpression |
| Does XBP1 drive cholesterol production and immunosuppression? | XBP1 knockout cancer cells co-cultured with myeloid cells |
| How does LXR regulate LDLR via IDOL? | LXR or IDOL knockout/knock-in cells |
| What is the role of cholesterol in CDC pore formation? | Cholesterol-depleted cells treated with CDCs |
How to Study the cellular response to cholesterol Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality or modifiers | Identify regulators of cholesterol response |
| RNA-seq | Transcriptional changes | Measure LXR/SREBP2 target genes |
| Proteomics | Protein abundance and modifications | Assess mTORC1 and STING pathway |
| Filipin staining | Free cholesterol distribution | Visualize lysosomal cholesterol accumulation |
| Western blot | Protein phosphorylation and expression | Monitor mTORC1, STING, and IDOL |
| Luciferase reporter | Transcriptional activity | Measure LXR or STING activation |
| Co-culture assays | Immune cell polarization | Study XBP1-driven immunosuppression |
| Mass spectrometry | Cholesterol and metabolite levels | Quantify cholesterol biosynthesis |
CRISPR Screens for Cholesterol Response Genes
Genome-wide CRISPR knockout screens can identify genes that regulate cellular response to cholesterol. For example, screens in cancer cells under cholesterol-loaded conditions can reveal modifiers of progestin sensitivity or cGAS-STING activation.
Transcriptomics and Proteomics
RNA-seq and proteomics can measure changes in gene expression and protein abundance upon cholesterol stimulation. This helps identify LXR target genes, SREBP2 targets, and inflammatory mediators.
Imaging and Cholesterol Quantification
Fluorescent cholesterol probes (e.g., filipin) and mass spectrometry can quantify cholesterol distribution and accumulation. Imaging can visualize lysosomal cholesterol and CDC pore formation.
Signaling Assays
Western blotting for mTORC1 targets (e.g., S6K, 4E-BP1) and cGAS-STING components can assess pathway activation. Luciferase reporters for LXR or STING can monitor transcriptional responses.
How CRISPR Can Be Used to Study GO:0071397 cellular response to cholesterol
Knockout
CRISPR knockout of genes such as SLC38A9, NPC1, XBP1, or cGAS can reveal their causal roles in cellular response to cholesterol. For example, SLC38A9 knockout abolishes cholesterol-induced mTORC1 activation, and XBP1 knockout reduces cholesterol production and immunosuppression.
Point Mutation
Point mutations can model disease-associated variants, such as NPC1 mutations that impair cholesterol trafficking. CRISPR point mutation can also dissect phosphorylation sites in signaling proteins like STING or mTORC1 components.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP-SLC38A9 or HA-IDOL) allows visualization and immunoprecipitation. Knock-in of reporter genes under cholesterol-responsive promoters can monitor transcriptional responses.
Overexpression
Overexpression of cholesterol biosynthesis enzymes (e.g., HMGCR) or transcription factors (e.g., SREBP2, XBP1) can mimic disease states and test sufficiency. For instance, HMGCR overexpression inhibits cGAS-STING and promotes radioresistance.
How EDITGENE Supports cellular response to cholesterol Research
Researchers studying cellular response to cholesterol-related genes often need to determine whether a candidate gene is causally involved in cholesterol sensing, signaling, or disease resistance. EDITGENE provides comprehensive CRISPR services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cellular response to cholesterol research.
Frequently Asked Questions About cellular response to cholesterol
What is GO:0071397 cellular response to cholesterol?
GO:0071397 is a Gene Ontology term for any process that results in a change in state or activity of a cell as a result of a cholesterol stimulus.
What genes are involved in cellular response to cholesterol?
Key genes include SLC38A9, NPC1, mTORC1, LXR, IDOL, LDLR, XBP1, cGAS, and STING.
How does cholesterol activate mTORC1?
Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex.
What is the role of LXR in cholesterol response?
LXR regulates cholesterol uptake through IDOL-dependent ubiquitination of the LDL receptor.
How does cholesterol cause progestin resistance in endometrial cancer?
Cholesterol desensitizes endometrial cancer to progestin by attenuating progestin signaling.
Does cholesterol affect radiotherapy response in colorectal cancer?
Yes, radiotherapy-induced cholesterol biosynthesis inhibits cGAS-STING activation and contributes to treatment resistance.
What are cholesterol-dependent cytolysins?
CDCs are bacterial toxins that bind cholesterol to form pores, and the cellular response to them is a specialized case of cholesterol response.
How does XBP1 influence cholesterol and immunity?
Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of myeloid cells by promoting cholesterol production.
What experimental models are used to study cellular response to cholesterol?
CRISPR knockout, knock-in, overexpression, and CRISPR screens in cancer and immune cells.
Why is cellular response to cholesterol important for disease?
It is implicated in cancer therapy resistance, innate immunity, inflammation, and metabolic disorders.
Conclusion
Cellular response to cholesterol (GO:0071397) is a fundamental biological process that integrates lipid sensing with signaling, transcription, and immune regulation. Key discoveries such as lysosomal cholesterol activation of mTORC1 via SLC38A9-NPC1, LXR-IDOL regulation of LDLR, and cholesterol-mediated therapy resistance in cancer highlight its broad relevance. Targeting this response may offer new therapeutic strategies. EDITGENE provides the CRISPR tools and services to dissect these mechanisms with precision.
References
- 1. Hu J et al.. 2025. Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling.. Sci Transl Med 17(818):eadp0064 PMID: 41032624
- 2. Tall AR et al.. 2015. Cholesterol, inflammation and innate immunity.. Nat Rev Immunol 15(2):104-16 PMID: 25614320
- 3. Cassidy SK et al.. 2013. More than a pore: the cellular response to cholesterol-dependent cytolysins.. Toxins (Basel) 5(4):618-36 PMID: 23584137
- 4. Castellano BM et al.. 2017. Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex.. Science 355(6331):1306-1311 PMID: 28336668
- 5. Zhu L et al.. 2025. Cholesterol biosynthesis induced by radiotherapy inhibits cGAS-STING activation and contributes to colorectal cancer treatment resistance.. Exp Mol Med 57(5):1089-1105 PMID: 40355720
- 6. Zelcer N et al.. 2009. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.. Science 325(5936):100-4 PMID: 19520913
- 7. Yang Z et al.. 2022. Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production.. Cell Metab 34(12):2018-2035.e8 PMID: 36351432
- 8. Thapa R et al.. 2020. Interaction of Macrophages and Cholesterol-Dependent Cytolysins: The Impact on Immune Response and Cellular Survival.. Toxins (Basel) 12(9) PMID: 32825096
